ClinicalTrials.gov
ClinicalTrials.gov Menu

the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00419848
Recruitment Status : Unknown
Verified January 2008 by Shahid Beheshti University of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : January 9, 2007
Last Update Posted : January 29, 2008
Sponsor:
Information provided by:
Shahid Beheshti University of Medical Sciences

January 8, 2007
January 9, 2007
January 29, 2008
August 2006
January 2008   (Final data collection date for primary outcome measure)
change in acne lesions [ Time Frame: 12 weeks ]
Not Provided
Complete list of historical versions of study NCT00419848 on ClinicalTrials.gov Archive Site
global response rates, patient's own assessment, side effects and compliance [ Time Frame: 12 weeks ]
Not Provided
Not Provided
Not Provided
 
the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris
the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris
a comparison of efficacy and adverse side effects occurrence of Doxycycline and Azithromycin in the management of moderate acne vulgaris
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Acne
  • Drug: Doxycycline
    Cap 100mg- 100mg/daily
    Other Name: Razak lab
  • Drug: Azithromycin
    Azithromycin: Cap 250 mg- 500 mg single dose/daily - 3 times per week
    Other Name: kimidarou
  • Experimental: 1
    Intervention: Drug: Azithromycin
  • Active Comparator: 2
    Intervention: Drug: Doxycycline
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
100
Same as current
February 2008
January 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Between 18 to 30 year old
  • Moderate facial Acne(At least 10 inflammatory lesions with maximum 3 nodules and pseudocysts

Exclusion Criteria:

  • Pregnancy
  • Breast Feeding
  • Acne Fulminant
  • Acne conglobate
  • Isotretinoin therapy within past 6 months
  • topical treatment in last 2 weeks
  • use of systemic antibiotic in the last month
  • Hyperandrogenism symptoms
  • Menstrual irregularity
Sexes Eligible for Study: All
18 Years to 30 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
 
NCT00419848
src-hmj-1385
Not Provided
Not Provided
Not Provided
Skin research center, Shaheed Beheshti Medical unversity
Shahid Beheshti University of Medical Sciences
Not Provided
Study Chair: Parviz Toossi, M.D. Skin Research Center
Principal Investigator: Hamideh Moravvej, M.D. Skin Research Center
Principal Investigator: Akbar Mousazadeh halim, M.D. Skin Research Center
Shahid Beheshti University of Medical Sciences
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP